Edgar Filing: NL INDUSTRIES INC

nl2q10q.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934


For the quarterly period ended June 30, 2010
Commission file number 1-640


NL INDUSTRIES, INC.
(Exact name of registrant as specified in its charter)


New Jersey	13-5267260
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification No.)


5430 LBJ Freeway, Suite 1700
Dallas, Texas 75240-2697
(Address of principal executive offices)

Registrant's telephone number, including area code: (972) 233-1700

Indicate by check mark:

Whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months and (2) has been subject to such filing requirements for the past 90 days. Yes X No

Whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). * Yes No

*	The registrant has not yet been phased into the interactive data requirements.

Whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company (as defined in Rule 12b-2 of the Securities Exchange Act of 1934). Large accelerated filer Accelerated filer X Non-accelerated filer Smaller reporting company

Whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes No X

Number of shares of the registrant's common stock outstanding on July 30, 2010: 48,630,934.

NL INDUSTRIES, INC. AND SUBSIDIARIES

INDEX

		Page
		number

Part I.	FINANCIAL INFORMATION

Item 1.	Financial Statements

	Condensed Consolidated Balance Sheets -
	December 31, 2009; June 30, 2010 (unaudited)	3

	Condensed Consolidated Statements of Operations (unaudited)-
	Three and six months ended June 30, 2009 and 2010	5

	Condensed Consolidated Statement of Equity
	and Comprehensive Loss -
	Six months ended June 30, 2010 (unaudited)	6

	Condensed Consolidated Statements of Cash Flows (unaudited) -
	Six months ended June 30, 2009 and 2010	7

	Notes to Condensed Consolidated Financial Statements
	(unaudited)	9

Item 2.	Management's Discussion and Analysis of Financial
	Condition and Results of Operations	23

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	42

Item 4.	Controls and Procedures	42

Part II.	OTHER INFORMATION

Item 1.	Legal Proceedings	44

Item 1A.	Risk Factors	45
Item 6.	Exhibits	45

Items 2, 3, 4 and 5 of Part II are omitted because there is no information to report

- 2 -

NL INDUSTRIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands)

ASSETS	December 31, 2009		June 30, 2010
			(unaudited)

Current assets:
Cash and cash equivalents	$	24,555	$	8,944
Restricted cash and cash equivalents		7,157		8,208
Marketable securities		5,225		-
Accounts and other receivables, net		17,053		19,113
Inventories, net		16,266		17,963
Prepaid expenses and other		1,349		1,979
Deferred income taxes		5,039		5,038

Total current assets		76,644		61,245

Other assets:
Marketable equity securities		85,073		84,610
Investment in Kronos Worldwide, Inc.		112,766		130,615
Goodwill		44,316		44,311
Assets held for sale		2,800		2,800
Other assets, net		17,026		16,690

Total other assets		261,981		279,026

Property and equipment:
Land		12,368		12,388
Buildings		34,261		34,169
Equipment		126,203		126,783
Construction in progress		1,180		1,082
		174,012		174,422
Less accumulated depreciation		109,646		112,560

Net property and equipment		64,366		61,862

Total assets	$	402,991	$	402,133

- 3 -

NL INDUSTRIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS (CONTINUED)

(In thousands)

LIABILITIES AND EQUITY	December 31, 2009			June 30, 2010
				(unaudited)

Current liabilities:
Current maturities of long-term debt	$	-		$	3,300
Accounts payable		6,664			8,597
Accrued liabilities		26,549			15,508
Accrued environmental costs		8,328			5,792
Income taxes		332			127

Total current liabilities		41,873			33,324

Non-current liabilities:
Long-term debt		42,540			64,730
Accrued environmental costs		37,518			36,916
Accrued pension costs		12,233			11,622
Accrued postretirement benefit (OPEB) costs		8,307			8,129
Deferred income taxes		55,750			58,381
Other		19,112			19,062

Total non-current liabilities		175,460			198,840

Equity:
NL Stockholders' equity:
Common stock		6,076			6,078
Additional paid-in capital		311,939			299,469
Retained earnings (deficit)		-			-
Accumulated other comprehensive loss		(143,411	)		(146,325	)

Total NL stockholders' equity		174,604			159,222

Noncontrolling interest in subsidiary		11,054			10,747

Total equity		185,658			169,969

Total liabilities and equity	$	402,991		$	402,133

Commitments and contingencies (Notes 10 and 11)

See accompanying Notes to Condensed Consolidated Financial Statements.

- 4 -

NL INDUSTRIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

	Three months ended June 30,						Six months ended June 30,
	2009			2010			2009			2010
	(unaudited)

Net sales	$	29,239		$	34,384		$	57,715		$	67,184
Cost of sales		22,993			25,529			46,695			49,231

Gross margin		6,246			8,855			11,020			17,953

Selling, general and administrative expense		6,451			6,037			12,130			13,341
Other operating income (expense):
Insurance recoveries		1,989			96			2,714			18,271
Litigation settlement gain		11,313			-			11,313			-
Litigation settlement expense		-			-			-			(32,174	)
Assets held for sale write-down		(717	)		-			(717	)		-
Other income (expense), net		(8	)		237			(39	)		215
Corporate expense		(4,956	)		(2,689	)		(9,322	)		(7,344	)

Income (loss) from operations		7,416			462			2,839			(16,420	)

Equity in net income (loss) of Kronos Worldwide, Inc.		(7,868	)		6,941			(17,422	)		22,337
Other income (expense):
Interest and dividends		692			641			1,415			1,247
Interest expense		(293	)		(303	)		(616	)		(500	)

Income (loss) before taxes		(53	)		7,741			(13,784	)		6,664

Provision for income taxes		2,297			3,228			484			4,571

Net income (loss)		(2,350	)		4,513			(14,268	)		2,093

Noncontrolling interest in net income (loss) of subsidiary		(206	)		223			(281	)		98

Net income (loss) attributable to NL stockholders	$	(2,144	)	$	4,290		$	(13,987	)	$	1,995

Amounts attributable to NL stockholders:

Basic and diluted net income (loss) per share	$	(.04	)	$	.09		$	(.29	)	$	(.01	)

Cash dividend per share	$	.125		$	.125		$	.25		$	.25


Basic and diluted average shares outstanding		48,609			48,626			48,605			48,622

See accompanying Notes to Condensed Consolidated Financial Statements.

- 5 -

NL INDUSTRIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENT OF EQUITY AND COMPREHENSIVE LOSS

Six months ended June 30, 2010

(In thousands)

	NL Stockholders’ Equity
									Accumulated
			Additional			Retained			other			Noncontrolling
	Common		paid-in			earnings			comprehensive			interest in			Total			Comprehensive
	stock		capital			(deficit)			loss			subsidiary			equity			loss
									(unaudited)

Balance at December 31, 2009	$	6,076	$	311,939		$	-		$	(143,411	)	$	11,054		$	185,658

Net income		-		-			1,995			-			98			2,093		$	2,093

Other comprehensive loss, net		-		-			-			(2,914	)		(10	)		(2,924	)		(2,924	)

Issuance of NL common stock		2		131			-			-			-			133

Dividends		-		(10,162	)		(1,995	)		-			(404	)		(12,561	)

Other, net		-		(2,439	)		-			-			9			(2,430	)

Balance at June 30, 2010	$	6,078	$	299,469		$	-		$	(146,325	)	$	10,747		$	169,969

Comprehensive loss																		$	(831	)

See accompanying Notes to Condensed Consolidated Financial Statements.

- 6 -

NL INDUSTRIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

	Six months ended June 30,
	2009			2010
	(unaudited)
Cash flows from operating activities:
Net income (loss)	$	(14,268	)	$	2,093
Depreciation and amortization		4,250			3,953
Deferred income taxes		(1,689	)		4,251
Equity in net (income) loss of Kronos Worldwide, Inc.		17,422			(22,337	)
Benefit plan expense greater (less) than cash funding:
Defined benefit pension expense		387			391
Other postretirement benefit expense		186			129
Litigation settlement gain		(11,313	)		-
Litigation settlement expense:
Accrued		-			32,174
Settlement payments made		-			(19,012	)
Assets held for sale write-down		717			-
Other, net		805			530
Change in assets and liabilities:
Accounts and other receivables, net		8,533			(4,817	)
Inventories, net		3,634			(2,098	)
Prepaid expenses and other		1,272			(625	)
Accrued environmental costs		(3,381	)		(3,138	)
Accounts payable and accrued liabilities		(3,444	)		(817	)
Income taxes		(1,461	)		(60	)
Accounts with affiliates		305			3,200
Other, net		(1,235	)		(768	)

Net cash provided by (used in) operating activities		720			(6,951	)

Cash flows from investing activities:
Capital expenditures		(1,245	)		(1,211	)
Proceeds from real estate–related litigation settlement gain		11,800			-
Change in restricted cash equivalents and marketable debt securities, net		(62	)		4,174
Collections of loans to affiliates		5,590			-
Collection of note receivable		261			-
Proceeds from disposal of marketable securities		61			-
Purchase of:
Kronos common stock		(139	)		-
Valhi common stock		(33	)		-

Net cash provided by investing activities		16,233			2,963

- 7 -

NL INDUSTRIES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)

(In thousands)

	Six months ended June 30,
	2009			2010
	(unaudited)

Cash flows from financing activities:
Cash dividends paid	$	(12,152	)	$	(12,157	)
Distributions to noncontrolling interests in subsidiary		(403	)		(404	)
Proceeds from issuance of common stock		84			68
Repurchase of noncontrolling interest in subsidiary		-			(6,988	)
Indebtedness:
Borrowings		-			7,800
Repayments		(750	)		-
Deferred financing costs paid		(96	)		(28	)

Net cash used in financing activities		(13,317	)		(11,709	)

Cash and cash equivalents - net change from:
Operating, investing and financing activities		3,636			(15,697	)
Currency translation		4			86
Cash and cash equivalents at beginning of period		16,450			24,555

Cash and cash equivalents at end of period	$	20,090		$	8,944


Supplemental disclosures:
Cash paid (received) for:
Interest	$	870		$	185
Income taxes, net		2,787			(2,077	)
Non-cash investing activity:
Accrual for capital expenditures		136			58

Non-cash financing activity:
Promissory note payable incurred in connection with litigation settlement		-			18,000

See accompanying Notes to Condensed Consolidated Financial Statements.

- 8 -

NL INDUSTRIES, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2010

(unaudited)

Note 1 - Organization and basis of presentation:

Organization - We are majority-owned by Valhi, Inc. (NYSE: VHI), which owns approximately 83% of our outstanding common stock at June 30, 2010. Valhi is majority-owned by subsidiaries of Contran Corporation. Substantially all of Contran's outstanding voting stock is held by trusts established for the benefit of certain children and grandchildren of Harold C. Simmons (for which Mr. Simmons is the sole trustee) or is held directly by Mr. Simmons or other persons or entities related to Mr. Simmons. Consequently, Mr. Simmons may be deemed to control Contran, Valhi and us.

Basis of presentation - Consolidated in this Quarterly Report are the results of our majority-owned subsidiary, CompX International Inc. We also own 36% of Kronos Worldwide, Inc. which we account for by the equity method. CompX (NYSE: CIX) and Kronos (NYSE: KRO) each file periodic reports with the Securities and Exchange Commission (“SEC”).

The unaudited Condensed Consolidated Financial Statements contained in this Quarterly Report have been prepared on the same basis as the audited Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2009 that we filed with the SEC on March 9, 2010 (the “2009 Annual Report”). In our opinion, we have made all necessary adjustments (which include only normal recurring adjustments) in order to state fairly, in all material respects, our consolidated financial position, results of operations and cash flows as of the dates and for the periods presented. We have condensed the Consolidated Balance Sheet at December 31, 2009 contained in this Quarterly Report as compared to our audited Consolidated Financial Statements at that date, and we have omitted certain information and footnote disclosures (including those related to the Consolidated Balance Sheet at December 31, 2009) normally included in financial statements prepared in accordance with accounting principals generally accepted in the United States of America (“GAAP”). Our results of operations for the interim period ended June 30, 2010 may not be indicative of our operating results for the full year. The Condensed Consolidated Financial Statements contained in this Quarterly Report should be read in conjunction with our 2009 Consolidated Financial Statements contained in our 2009 Annual Report.

Unless otherwise indicated, references in this report to “NL,” “we,” “us” or “our” refer to NL Industries, Inc. and its subsidiaries and Kronos, taken as a whole.

- 9 -

Note 2 – Accounts and other receivables, net:

	December 31, 2009			June 30, 2010
	(In thousands)

Trade receivables	$	12,204		$	17,261
Accrued insurance recoveries		465			92
Other receivables		133			106
Receivable from affiliates:
Income taxes from Valhi		2,880			424
Other		8			2
Refundable income taxes		1,844			1,627
Allowance for doubtful accounts		(481	)		(399	)

Total	$	17,053		$	19,113

Note 3 – Inventories, net:

	December 31, 2009		June 30, 2010
	(In thousands)

Raw materials	$	4,830	$	6,414
Work in process		6,151		6,800
Finished products		5,285		4,749

Total	$	16,266	$	17,963

Note 4 - Marketable securities:

	December 31, 2009		June 30, 2010
	(In thousands)

Current assets (available-for-sale)-
Restricted debt securities	$	5,225	$	-

Noncurrent assets (available-for-sale):
Valhi common stock	$	66,930	$	59,121
TIMET common stock		18,143		25,489

Total	$	85,073	$	84,610

- 10 -

	Fair Value Measurements
	Total		Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)
	(in thousands)
December 31, 2009:
Current assets (available-for-sale)-
Restricted debt securities	$	5,225	$	-	$	5,225

Noncurrent assets (available-for-sale):
Valhi common stock	$	66,930	$	66,930	$	-
TIMET common stock		18,143		18,143		-

Total	$	85,073	$	85,073	$	-

June 30, 2010:
Noncurrent assets (available-for-sale):
Valhi common stock	$	59,121	$	59,121	$	-
TIMET common stock		25,489		25,489		-

Total	$	84,610	$	84,610	$	-

We held no level 3 securities at June 30, 2010 or December 31, 2009. Restricted debt securities at December 31, 2009 collateralized certain of our outstanding letters of credit. Such investments matured during the first half of 2010 and are now held in investments classified as restricted cash equivalents at June 30, 2010.

Our investments in related parties’ Valhi and Titanium Metals Corporation (“TIMET”) common stock are accounted for as available-for-sale marketable equity securities carried at fair value based on quoted market prices, a Level 1 input as defined by Accounting Standards Codification (“ASC”) Topic 820-10-35, Fair Value Measurements and Disclosures. We held approximately 4.2% of Valhi’s outstanding common stock and .8% of TIMET’s outstanding common stock at June 30, 2010. At December 31, 2009 and June 30, 2010, we owned approximately 4.8 million shares of Valhi common stock and 1.4 million shares of TIMET common stock. At June 30, 2010, the quoted market price of Valhi’s and TIMET’s common stock was $12.34 and $17.59 per share, respectively. At December 31, 2009, such quoted market prices were $13.97 and $12.52 per share, respectively.

Note 5 – Investment in Kronos Worldwide, Inc.:

At December 31, 2009 and June 30, 2010, we owned approximately 17.6 million shares of Kronos common stock. At June 30, 2010, the quoted market price of Kronos’ common stock was $19.50 per share, or an aggregate market value of $343.4 million. At December 31, 2009, the quoted market price was $16.25, or an aggregate market value of $286.2 million. We have pledged certain shares of our Kronos common stock (and a nominal number of shares of our CompX common stock), as indicated in Note 11.

- 11 -

The change in the carrying value of our investment in Kronos during the first six months of 2010 is summarized below:

	Amount
	(In millions)

Balance at the beginning of the period	$	112.8
Equity in net income of Kronos		22.3
Other, principally equity in other comprehensive loss items of Kronos		(4.5	)

Balance at the end of the period	$	130.6

Selected financial information of Kronos is summarized below:

	December 31, 2009		June 30, 2010
	(In millions)

Current assets	$	529.9	$	534.7
Property and equipment, net		499.7		437.9
Investment in TiO2 joint venture		98.7		97.2
Other noncurrent assets		196.7		192.6

Total assets	$	1,325.0	$	1,262.4

Current liabilities	$	215.4	$	203.0
Long-term debt		611.1		530.3
Accrued pension and postretirement benefits		131.7		114.1
Other non-current liabilities		54.3		52.9
Stockholders’ equity		312.5		362.1

Total liabilities and stockholders’ equity	$	1,325.0	$	1,262.4

	Three months ended June 30,					Six months ended June 30,
	2009			2010		2009			2010
	(In millions)					(In millions)

Net sales	$	282.0		$	380.1	$	530.1		$	699.8
Cost of sales		267.9			294.9		511.8			554.1
Income (loss) from operations		(21.9	)		38.8		(48.2	)		60.5
Net income (loss)		(21.8	)		19.3		(48.4	)		62.1

Note 6 – Intangible and other noncurrent assets:

	December 31, 2009		June 30, 2010
	(In thousands)

Promissory note receivable	$	15,000	$	15,000
Patents and other intangible assets, net		1,408		1,113
Other		618		577

Total	$	17,026	$	16,690

- 12 -

Note 7 – Accrued liabilities:

	December 31, 2009		June 30, 2010
	(In thousands)

Current:
Employee benefits	$	7,561	$	8,008
Professional fees and legal settlements		6,747		2,776
Payable to affiliates:
Accrued interest payable to TIMET		-		579
Other		583		1,322
Reserve for uncertain tax positions		59		-
Other		11,599		2,823

Total	$	26,549	$	15,508

Noncurrent:
Reserve for uncertain tax positions	$	16,936	$	16,937
Insurance claims and expenses		659		630
Other		1,517		1,495

Total	$	19,112	$	19,062

Note 8 – Long-term debt:

	December 31, 2009		June 30, 2010
	(In thousands)
NL:
Promissory note payable to Valhi	$	-	$	2,800
Promissory note issued in conjunction with litigation settlement		-		18,000
Subtotal		-		20,800

Subsidiary debt:
CompX credit facility		-		5,000
CompX promissory note payable to TIMET		42,540		42,230
Subtotal		42,540		47,230

Total debt		42,540		68,030

Less current maturities		-		3,300

Total long-term debt	$	42,540	$	64,730

NL - In June 2010, we entered into a promissory note with Valhi that allows us to borrow up to $40 million. Our borrowings from Valhi under the revolving note are unsecured, bear interest at prime rate plus 2.75% (6.00% at June 30, 2010) with all principal due on demand, but in any event no later than December 31, 2011. The amount of the outstanding borrowings at any time is solely at the discretion of Valhi.

The $18.0 million promissory note is discussed in Note 11.

- 13 -

CompX - During the first six months of 2010, CompX borrowed $5.0 million under its revolving bank credit facility that matures in January 2012. The average interest rate on this outstanding borrowing at June 30, 2010 was 3.6%.

Note 9 – Employee benefit plans:

Defined benefit plans - The components of net periodic defined benefit pension cost (income) are presented in the table below.

	Three months ended June 30,						Six months ended June 30,
	2009			2010			2009			2010
	(In thousands)

Interest cost	$	705		$	736		$	1,428		$	1,456
Expected return on plan assets		(822	)		(838	)		(1,640	)		(1,684	)
Recognized actuarial losses		302			308			599			621

Total	$	185		$	206		$	387		$	393

Postretirement benefits - The components of net periodic postretirement benefits other than pension cost are presented in the table below.

	Three months ended June 30,						Six months ended June 30,
	2009			2010			2009			2009
	(In thousands)

Interest cost	$	138		$	110		$	276		$	219
Amortization of prior service credit		(45	)		(45	)		(90	)		(90	)

Total	$	93		$	65		$	186		$	129

Contributions – We expect our 2010 contributions for our pension and other postretirement benefit plans to be consistent with the amount disclosed in our 2009 Annual Report.

Note 10 - Income tax provision (benefit):

	Six months ended June 30,
	2009			2010
	(In millions)

Expected tax provision (benefit) at U.S. federal statutory income tax rate of 35%	$	(4.8	)	$	2.3
Non-U.S. tax rates		-			(.2	)
Incremental U.S. tax and rate differences on equity in earnings of non-tax group companies		4.7			2.4
U.S. state income taxes, net		.2			.1
Change in reserve for uncertain tax positions, net		.3			-
Nondeductible expenses		.1			.1
Other, net		-			(.1	)

Total	$	.5		$	4.6

Tax authorities are examining certain of our U.S. and non-U.S. tax returns and have or may propose tax deficiencies, including penalties and interest. We cannot guarantee that these tax matters will be resolved in our favor due to the inherent uncertainties involved in settlement initiatives and court and tax proceedings. We believe we have adequate accruals for additional taxes and related interest expense which could ultimately result from tax examinations. We believe the ultimate disposition of tax examinations should not have a material adverse effect on our consolidated financial position, results of operations or liquidity. We currently estimate that our unrecognized tax benefits will decrease by approximately $.1 million during the next twelve months due to certain statutes of limitations.

- 14 -

Under GAAP, we are required to recognize a deferred income tax liability with respect to the incremental U.S. (federal and state) and non-U.S. withholding taxes that would be incurred when undistributed earnings of a non-U.S. subsidiary are subsequently repatriated, unless management has determined that those undistributed earnings are permanently reinvested for the foreseeable future. Prior to March 31, 2010, we had not recognized a deferred income tax liability related to incremental income taxes on the pre-2005 undistributed earnings of CompX’s Taiwanese subsidiary, as those earnings were deemed to be permanently reinvested. GAAP requires us to reassess the permanent reinvestment conclusion on an ongoing basis to determine if our intentions have changed. At the end of March 2010, and based primarily upon changes in our cash management plans, we determined that all of the undistributed earnings of CompX’s Taiwanese subsidiary can no longer be considered to be permanently reinvested in Taiwan. Accordingly, in the first quarter of 2010 we recognized an aggregate $1.9 million provision for deferred income taxes on the pre-2005 undistributed earnings of CompX’s Taiwanese subsidiary. Consequently, all of the undistributed earnings of CompX’s non-U.S. operations are now considered to be not permanently reinvested.

Note 11 – Commitments and contingencies:

Lead pigment litigation

Our former operations included the manufacture of lead pigments for use in paint and lead-based paint. We, other former manufacturers of lead pigments for use in paint and lead-based paint (together, the “former pigment manufacturers”), and the Lead Industries Association (“LIA”), which discontinued business operations in 2002, have been named as defendants in various legal proceedings seeking damages for personal injury, property damage and governmental expenditures allegedly caused by the use of lead-based paints. Certain of these actions have been filed by or on behalf of states, counties, cities or their public housing authorities and school districts, and certain others have been asserted as class actions. These lawsuits seek recovery under a variety of theories, including public and private nuisance, negligent product design, negligent failure to warn, strict liability, breach of warranty, conspiracy/concert of action, aiding and abetting, enterprise liability, market share or risk contribution liability, intentional tort, fraud and misrepresentation, violations of state consumer protection statutes, supplier negligence and similar claims.

The plaintiffs in these actions generally seek to impose on the defendants responsibility for lead paint abatement and health concerns associated with the use of lead-based paints, including damages for personal injury, contribution and/or indemnification for medical expenses, medical monitoring expenses and costs for educational programs. To the extent the plaintiffs seek compensatory or punitive damages in these actions, such damages are generally unspecified. In some cases, the damages are unspecified pursuant to the requirements of applicable state law. A number of cases are inactive or have been dismissed or withdrawn. Most of the remaining cases are in various pre-trial stages. Some are on appeal following dismissal or summary judgment rulings in favor of either the defendants or the plaintiffs. In addition, various other cases (in which we are not a defendant) are pending that seek recovery for injury allegedly caused by lead pigment and lead-based paint. Although we are not a defendant in these cases, the outcome of these cases may have an impact on cases that might be filed against us in the future.

- 15 -

We believe that these actions are without merit, and we intend to continue to deny all allegations of wrongdoing and liability and to defend against all actions vigorously. We do not believe it is probable that we have incurred any liability with respect to all of the lead pigment litigation cases to which we are a party, and liability to us that may result, if any, in this regard cannot be reasonably estimated, because:

·	we have never settled any of the market share, risk contribution, intentional tort, fraud, nuisance, supplier negligence, strict liability, breach of warranty, conspiracy, misrepresentation, aiding and abetting, enterprise liability, or statutory cases,

·	no final, non-appealable adverse verdicts have ever been entered against us, and

·	we have never ultimately been found liable with respect to any such litigation matters.

Accordingly, we have not accrued any amounts for any of the pending lead pigment and lead-based paint litigation cases. New cases may continue to be filed against us. We cannot assure you that we will not incur liability in the future in respect of any of the pending or possible litigation in view of the inherent uncertainties involved in court and jury rulings. The resolution of any of these cases could result in recognition of a loss contingency accrual that could have a material adverse impact on our net income for the interim or annual period during which such liability is recognized and a material adverse impact on our consolidated financial condition and liquidity.

Environmental matters and litigation

Our operations are governed by various environmental laws and regulations. Certain of our businesses are and have been engaged in the handling, manufacture or use of substances or compounds that may be considered toxic or hazardous within the meaning of applicable environmental laws and regulations. As with other companies engaged in similar businesses, certain of our past and current operations and products have the potential to cause environmental or other damage. We have implemented and continue to implement various policies and programs in an effort to minimize these risks. Our policy is to maintain compliance with applicable environmental laws and regulations at all of our plants and to strive to improve environmental performance. From time to time, we may be subject to environmental regulatory enforcement under U.S. and non-U.S. statutes, the resolution of which typically involves the establishment of compliance programs. It is possible that future developments, such as stricter requirements of environmental laws and enforcement policies, could adversely affect our production, handling, use, storage, transportation, sale or disposal of such substances. We believe that all of our facilities are in substantial compliance with applicable environmental laws.

Certain properties and facilities used in our former operations, including divested primary and secondary lead smelters and former mining locations, are the subject of civil litigation, administrative proceedings or investigations arising under federal and state environmental laws. Additionally, in connection with past operating practices, we are currently involved as a defendant, potentially responsible party (“PRP”) or both, pursuant to the Comprehensive Environmental Response, Compensation and Liability Act, as amended by the Superfund Amendments and Reauthorization Act (“CERCLA”), and similar state laws in various governmental and private actions associated with waste disposal sites, mining locations, and facilities we or our predecessors currently or previously owned, operated or were used by us or our subsidiaries, or their predecessors, certain of which are on the United States Environmental Protection Agency’s (“EPA”) Superfund National Priorities List or similar state lists. These proceedings seek cleanup costs, damages for personal injury or property damage and/or damages for injury to natural resources. Certain of these proceedings involve claims for substantial amounts. Although we may be jointly and severally liable for these costs, in most cases we are only one of a number of PRPs who may also be jointly and severally liable, and among whom costs may be shared or allocated. In addition, we are also a party to a number of personal injury lawsuits filed in various jurisdictions alleging claims related to environmental conditions alleged to have resulted from our operations.

- 16 -

Environmental obligations are difficult to assess and estimate for numerous reasons including the:

·	complexity and differing interpretations of governmental regulations,

·	number of PRPs and their ability or willingness to fund such allocation of costs,

·	financial capabilities of the PRPs and the allocation of costs among them,

·	solvency of other PRPs,

·	multiplicity of possible solutions,

·	number of years of investigatory, remedial and monitoring activity required and

·	number of years between former operations and notice of claims and lack of information and documents about the former operations.

In addition, the imposition of more stringent standards or requirements under environmental laws or regulations, new developments or changes regarding site cleanup costs or allocation of costs among PRPs, solvency of other PRPs, the results of future testing and analysis undertaken with respect to certain sites or a determination that we are potentially responsible for the release of hazardous substances at other sites, could cause our expenditures to exceed our current estimates. Because we may be jointly and severally liable for the total remediation cost at certain sites, the amount for which we are ultimately liable may exceed our accruals due to, among other things, the reallocation of costs among PRPs or the insolvency of one or more PRPs. We cannot assure you that actual costs will not exceed accrued amounts or the upper end of the range for sites for which estimates have been made, and we cannot assure you that costs will not be incurred for sites where no estimates presently can be made. Further, additional environmental matters may arise in the future. If we were to incur any future liability, this could have a material adverse effect on our consolidated financial statements, results of operations and liquidity.

We record liabilities related to environmental remediation obligations when estimated future expenditures are probable and reasonably estimable. We adjust our environmental accruals as further information becomes available to us or as circumstances change. Such further information or changed circumstances could include, among other things, new assertions of liability, revised expectations regarding the nature, timing and extent of any remediation required or revised estimates of the allocation of remediation costs among PRPs, and such further information or changed circumstances could result in an increase or reduction in our accrued environmental costs. We generally do not discount estimated future expenditures to their present value due to the uncertainty of the timing of the pay out. We recognize recoveries of remediation costs from other parties, if any, as assets when their receipt is deemed probable. At June 30, 2010, we have not recognized any receivables for recoveries.

We do not know and cannot estimate the exact time frame over which we will make payments for our accrued environmental costs. The timing of payments depends upon a number of factors including the timing of the actual remediation process; which in turn depends on factors outside of our control. At each balance sheet date, we estimate the amount of our accrued environmental costs which we expect to pay within the next twelve months, and we classify this estimate as a current liability. We classify the remaining accrued environmental costs as a noncurrent liability.

- 17 -

Changes in the accrued environmental costs during the first six months of 2010 are as follows:

	Amount
	(In thousands)

Balance at the beginning of the period	$	45,846
Reductions charged against expense, net		(883	)
Payments, net		(2,255	)

Balance at the end of the period	$	42,708

Amounts recognized in the balance sheet at the end of the period:
Current liability	$	5,792
Noncurrent liability		36,916

Total	$	42,708

On a quarterly basis, we evaluate the potential range of our liability at sites where we have been named as a PRP or defendant, including sites for which our wholly-owned environmental management subsidiary, NL Environmental Management Services, Inc., (“EMS”), has contractually assumed our obligations. At June 30, 2010, we had accrued approximately $43 million, related to approximately 50 sites, which are environmental matters that we believe are at the present time and/or in their current phase reasonably estimable. The upper end of the range of reasonably possible costs to us for sites for which we believe it is possible to estimate costs is approximately $78 million, including the amount currently accrued. We have not discounted these estimates to present value.

We believe that it is not possible to estimate the range of costs for certain sites. At June 30, 2010, there were approximately 5 sites for which we are not currently able to estimate a range of costs. For these sites, generally the investigation is in the early stages, and we are unable to determine whether or not we actually had any association with the site, the nature of our responsibility, if any, for the contamination at the site and the extent of contamination at and cost to remediate the site. The timing and availability of information on these sites is dependent on events outside of our control, such as when the party alleging liability provides information to us. At certain of these previously inactive sites, we have received general and special notices of liability from the EPA and/or state agencies alleging that we, sometimes with other PRPs, are liable for past and future costs of remediating environmental contamination allegedly caused by former operations. These notifications may assert that we, along with any other alleged PRPs, are liable for past and/or future clean-up costs that could be material to us if we are ultimately found liable.

In July 2010, we entered into a settlement agreement with another PRP pursuant to which, among other things, the other PRP reimbursed us for certain remediation costs we had previously incurred for certain sites related to one of our former business units, and PRP also affirmed its full responsibility to indemnify us for all claims (environmental or otherwise) with respect to certain specified sites related to such former business unit as well as indemnify us for any future claims that may arise related to such former business unit. As a result of the July 2010 settlement agreement, in the third quarter of 2010 we expect to recognize a litigation settlement gain of $5.2 million, consisting of $3.1 million related to the PRP’s cash reimbursement of prior remediation costs and $2.1 million related to a reduction in our accrued environmental remediation costs resulting from the PRP’s agreement to indemnify us.

- 18 -

Insurance coverage claims

We are involved in certain legal proceedings with a number of our former insurance carriers regarding the nature and extent of the carriers’ obligations to us under insurance policies with respect to certain lead pigment and asbestos lawsuits. The issue of whether insurance coverage for defense costs or indemnity or both will be found to exist for our lead pigment and asbestos litigation depends upon a variety of factors, and we cannot assure you that such insurance coverage will be available.

We have agreements with two former insurance carriers pursuant to which the carriers reimburse us for a portion of our future lead pigment litigation defense costs, and one such carrier reimburses us for a portion of our future asbestos litigation defense costs. We are not able to determine how much we will ultimately recover from these carriers for defense costs incurred by us because of certain issues that arise regarding which defense costs qualify for reimbursement. While we continue to seek additional insurance recoveries, we do not know if we will be successful in obtaining reimbursement for either defense costs or indemnity. Accordingly, these insurance recoveries are recognized when the receipt is probable and the amount is determinable.

We recognize insurance recoveries in income only when receipt of the recovery is probable and we are able to reasonably estimate the amount of the recovery.

For a complete discussion of certain litigation involving us and certain of our former insurance carriers, refer to our 2009 Annual Report.

Other litigation

In June 2010, the case captioned Contran Corporation, et al. v. Terry S. Casey, et al. (Case No. 07-04855, 192nd Judicial District Court, Dallas County, Texas) was dismissed with prejudice in accordance with the previously-reported settlement agreement. In May 2010, pursuant to such agreement, we paid $26.0 million in cash and we issued an $18.0 million long-term promissory note. The note bears interest, payable quarterly, at the prime rate. Fifty percent of the principal amount will be payable on each of December 1, 2011 and December 1, 2012. The note is collateralized by shares of Kronos and CompX common stock, owned by us, having an aggregate market value of at least 200% of the outstanding principal amount of the promissory note. Under certain conditions, we have agreed to prepay up to $4.0 million principal amount of such indebtedness.

For financial reporting purposes, we classified $32.2 million of the aggregate amount payable under the settlement agreement as a litigation settlement expense in respect of certain claims made by plaintiffs in the litigation. We had insurance coverage for a portion of such litigation settlement, and a substantial portion of the insurance recoveries we recognized in the first quarter of 2010 relates to such coverage. With respect to the other claim of the plaintiffs as it relates to the repurchase of their EMS noncontrolling interest, the resulting $2.5 million increase over our previous estimate of such payment is accounted for as a reduction in additional paid-in capital in accordance with GAAP.

- 19 -

We have been named as a defendant in various lawsuits in several jurisdictions, alleging personal injuries as a result of occupational exposure primarily to products manufactured by our former operations containing asbestos, silica and/or mixed dust. In addition, some plaintiffs allege exposure to asbestos from working in various facilities previously owned and/or operated by NL. There are approximately 1,226 of these types of cases pending, involving a total of approximately 2,670 plaintiffs. In addition, the claims of approximately 7,500 plaintiffs have been administratively dismissed or placed on the inactive docket in Ohio, Indiana and Texas state courts. We do not expect these claims will be re-opened unless the plaintiffs meet the courts’ medical criteria for asbestos-related claims. We have not accrued any amounts for this litigation because of the uncertainty of liability and inability to reasonably estimate the liability, if any. To date, we have not been adjudicated liable in any of these matters. Based on information available to us, including:

·	facts concerning historical operations,

·	the rate of new claims,

·	the number of claims from which we have been dismissed and

·	our prior experience in the defense of these matters,

we believe that the range of reasonably possible outcomes of these matters will be consistent with our historical costs (which are not material). Furthermore, we do not expect any reasonably possible outcome would involve amounts material to our consolidated financial position, results of operations or liquidity. We have sought and will continue to vigorously seek, dismissal and/or a finding of no liability from each claim. In addition, from time to time, we have received notices regarding asbestos or silica claims purporting to be brought against former subsidiaries, including notices provided to insurers with which we have entered into settlements extinguishing certain insurance policies. These insurers may seek indemnification from us.

CompX

On February 10, 2009, Humanscale Corporation filed a complaint with the U.S. International Trade Commission (“ITC”) requesting that the ITC commence an investigation pursuant to the Tariff Act of 1930 to evaluate allegations concerning the unlawful importation of certain adjustable keyboard related products into the U.S. by CompX’s Canadian subsidiary. The products were alleged to infringe certain claims under a U.S. patent held by Humanscale. The complaint sought as relief the barring of future imports of the products into the U.S. until the expiration of the related patent in March 2011. The ITC hearing was completed on December 4, 2009. On July 9, 2010, the ITC issued its final judgment that CompX had not infringed on the Humanscale patents and that the patents are invalid. The final judgment is subject to appeal.

On February 13, 2009, Humanscale filed a complaint for patent infringement in the United States District Court, Eastern District of Virginia, against CompX and its Canadian subsidiary involving the identical patent in question in the ITC case. On March 30, 2009, CompX filed for a stay in the U.S. District Court Action pending the completion of the related case before the ITC. On May 19, 2009, the court granted CompX’s motion to stay the Humanscale claim of patent infringement. With the issuance of the final determination in the ITC case on July 9, 2010, Humanscale may now proceed with its claim in U.S. District Court unless it chooses to appeal the ITC judgment. While the ITC determined that CompX did not infringe the patents and that the patents in question are invalid, the U.S. District Court is not bound by that determination.

In conjunction with CompX’s filing of a stay of Humanscale’s patent infringement claim in the U.S. District Court on March 30, 2009, CompX filed a counterclaim of patent infringement against Humanscale for infringement of certain of our keyboard support arm patents by Humanscale’s models 2G, 4G and 5G support arms. A jury trial was completed on February 25, 2010 relating to CompX’s counterclaims with the jury finding that Humanscale infringed on our patents and awarded damages to CompX in excess of $19 million for past royalties. We anticipate the judge to issue a final judgment in August 2010. The verdict is subject to appeal. Due to the uncertain nature of the ongoing legal proceedings we have not accrued a receivable for the amount of the award.

- 20 -

For a discussion of other legal proceedings to which we are a party, refer to our 2009 Annual Report.

In addition to the litigation described above, we and our affiliates are also involved in various other environmental, contractual, product liability, patent (or intellectual property), employment and other claims and disputes incidental to present and former businesses. In certain cases, we have insurance coverage for these items, although we do not expect additional material insurance coverage for environmental claims.

We currently believe that the disposition of all of these various other claims and disputes, individually or in the aggregate, should not have a material adverse effect on our consolidated financial position, results of operations or liquidity beyond the accruals already provided.

Note 12 - Financial instruments:

See Note 4 for information on how we determine fair value of our marketable securities.

The following table presents the financial instruments that are not carried at fair value but which require fair value disclosure at December 31, 2009 and June 30, 2010:

	December 31, 2009				June 30, 2010
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
	(in millions)
Cash and cash equivalents, current restricted cash equivalents and current marketable securities	$	36.9	$	36.9	$	17.2	$	17.2

Promissory note receivable		15.0		15.0		15.0		15.0

Notes payable to affiliates		42.2		42.2		45.0		45.0

CompX bank credit facility		-		-		5.0		5.0

Promissory note payable		-		-		18.0		18.0

Noncontrolling interest in CompX common stock		11.1		12.2		10.7		16.0

NL stockholders’ equity		174.6		337.4		159.2		296.6

The fair value of our noncurrent marketable equity securities, restricted marketable debt securities, noncontrolling interest in CompX and NL stockholder’s equity are based upon quoted market prices at each balance sheet date, which represent Level 1 inputs. The fair value of our promissory note receivable and our variable interest rate debt is deemed to approximate book value. Due to their near-term maturities, the carrying amounts of accounts receivable and accounts payable are considered equivalent to fair value. The fair values of our promissory note receivable, long-term debt and notes payable to affiliates are Level 2 inputs as defined by ASC Topic 820-10-35.

- 21 -

Note 13 – Earnings per share:

Earnings per share is based on the weighted average number of common shares outstanding during each period. A reconciliation of the numerator used in the calculation of earnings (loss) per share is presented in the following table:

	Three months ended June 30,					Six months ended June 30,
	2009			2010		2009			2010
	(in thousands)

Net income (loss) attributable to NL stockholders	$	(2,144	)	$	4,290	$	(13,987	)	$	1,995
Paid-in capital adjustment		-			-		-			(2,513	)
Adjusted net income (loss) attributable to NL Stockholders	$	(2,144	)	$	4,290	$	(13,987	)	$	(518	)

The paid-in capital adjustment is discussed in Note 11.

- 22 -

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

RESULTS OF OPERATIONS

Business and results of operations overview

We are primarily a holding company. We operate in the component products industry through our majority-owned subsidiary, CompX International Inc. We also own a non-controlling interest in Kronos Worldwide, Inc. Both CompX (NYSE: CIX) and Kronos (NYSE: KRO) file periodic reports with the Securities and Exchange Commission (“SEC”).

CompX is a leading manufacturer of security products, precision ball bearing slides and ergonomic computer support systems used in the office furniture, transportation, tool storage and a variety of other industries. CompX is also a leading manufacturer of stainless steel exhaust systems, gauges and throttle controls for the performance boat industry.

We account for our 36% non-controlling interest in Kronos by the equity method. Kronos is a leading global producer and marketer of value-added titanium dioxide pigments (“TiO2”). TiO2 is used for a variety of manufacturing applications including plastics, paints, paper and other industrial products.

Forward-looking information

This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this Quarterly Report on Form 10-Q that are not historical facts are forward-looking in nature. Statements found in this report including, but not limited to, the statements found in Item 2 - "Management’s Discussion and Analysis of Financial Condition and Results of Operations," are forward-looking statements that represent our beliefs and assumptions based on currently available information. In some cases you can identify these forward-looking statements by the use of words such as "believes," "intends," "may," "should," "could," "anticipates," "expected" or comparable terminology, or by discussions of strategies or trends. Although we believe the expectations reflected in forward-looking statements are reasonable, we do not know if these expectations will be correct. Forward-looking statements by their nature involve substantial risks and uncertainties that could significantly impact expected results. Actual future results could differ materially from those predicted. While it is not possible to identify all factors, we continue to face many risks and uncertainties. Among the factors that could cause our actual future results to differ materially from those described herein are the risks and uncertainties discussed in this Quarterly Report and those described from time to time in our other filings with the SEC, which include, but are not limited to, the following:

- 23 -

·	Future supply and demand for our products,

·	The extent of the dependence of certain of our businesses on certain market sectors,

·	The cyclicality of our businesses (such as Kronos’ TiO2 operations),

·	Customer inventory levels (such as the extent to which Kronos’ customers may, from time to time, accelerate purchases of TiO2 in advance of anticipated price increases or defer purchases of TiO2 in advance of anticipated price decreases),

·	Changes in raw material and other operating costs (such as energy and steel costs),

·	General global economic and political conditions (such as changes in the level of gross domestic product in various regions of the world and the impact of such changes on demand for, among other things, TiO2 and component products),

·	Possible disruption of our business or increases in the cost of doing business resulting from terrorist activities or global conflicts,

·	Competitive products and prices, including increased competition from low-cost manufacturing sources (such as China),

·	Customer and competitor strategies,

·	Potential consolidation or solvency of our competitors,

·	Demand for office furniture,

·	Demand for high performance marine components,

·	Substitute products,

·	The impact of pricing and production decisions,

·	Competitive technology positions,

·	The introduction of trade barriers,

·	Service industry employment levels,

·	Fluctuations in currency exchange rates (such as changes in the exchange rate between the U.S. dollar and each of the euro, the Norwegian krone, the Canadian dollar and the New Taiwan dollar),

·	Operating interruptions (including, but not limited to, labor disputes, leaks, natural disasters, fires, explosions, unscheduled or unplanned downtime and transportation interruptions),

·	The timing and amounts of insurance recoveries,

·	Our ability to maintain sufficient liquidity,

·	The extent to which our subsidiaries were to become unable to pay us dividends,

·	CompX’s and Kronos’ ability to renew or refinance credit facilities,

·	CompX’s ability to comply with covenants contained in its revolving bank credit facility,

·	The ultimate outcome of income tax audits, tax settlement initiatives or other tax matters,

·	Potential difficulties in integrating completed or future acquisitions,

·	Decisions to sell operating assets other than in the ordinary course of business,

·	Uncertainties associated with the development of new product features,

·	Our ability to utilize income tax attributes or changes in income tax rates related to such attributes, the benefits of which have been recognized under the more-likely-than-not recognition criteria,

·	Environmental matters (such as those requiring compliance with emission and discharge standards for existing and new facilities or new developments regarding environmental remediation at sites related to our former operations),

Government laws and regulations and possible changes therein (such as changes in government regulations which might impose various obligations on present and former manufacturers of lead pigment and lead-based paint, including us, with respect to asserted health concerns associated with the use of such products),

·	The ultimate resolution of pending litigation (such as our lead pigment and environmental matters) and

·	Possible future litigation.

Should one or more of these risks materialize or if the consequences of such a development worsen, or should the underlying assumptions prove incorrect, actual results could differ materially from those currently forecasted or expected. We disclaim any intention or obligation to update or revise any forward-looking statement whether as a result of changes in information, future events or otherwise.

- 24 -

Results of Operations

Net Income (Loss) Overview

Quarter Ended June 30, 2010 Compared to Quarter Ended June 30, 2009

Our net income attributable to NL stockholders was $4.3 million, or $.09 per share, in the second quarter of 2010 compared to a net loss of $2.1 million, or $.04 per share, in the second quarter of 2009. As more fully described below, our income per share increased from 2009 to 2010 due primarily to the net effect of:

·	equity in net income from Kronos in 2010 as compared to equity in losses in 2009,

·	a pre-tax litigation settlement gain of $11.3 million in 2009,

·	income from operations from component products in 2010 as compared to a loss in 2009,

·	lower corporate expenses of $2.3 million in 2010,

·	an asset held for sale write-down of $.7 million in 2009, and

·	lower insurance recoveries in 2010.

Our 2009 net loss attributable to NL stockholders includes:

·	a litigation settlement gain of $.15 per share related to the settlement of condemnation proceedings on real property we owned,

·	income of $.03 per share related to certain insurance recoveries, and

·	a write-down of assets held for sale of $.01 per share.

Six Months Ended June 30, 2010 Compared to Six Months Ended June 30, 2009

Our net income attributable to NL stockholders was $2.0 million, or $.01 loss per share, in the first six months of 2010 compared to a net loss of $14.0 million, or $.29 per share, in the first six months of 2009. As more fully described below, our income per share increased from 2009 to 2010 primarily due to the net effect of:

·	equity in net income from Kronos in 2010 as compared to equity in losses in 2009,

·	a pre-tax litigation settlement gain of $11.3 million in 2009,

·	income from operations from component products in 2010 as compared to a loss in 2009,

·	a litigation settlement expense in 2010 as discussed below,

·	lower corporate expenses of $2.0 million in 2010,

·	an asset held for sale write-down of $.7 million in 2009, and

·	higher insurance recoveries in 2010 primarily related to the litigation settlement expense.

Our 2010 net income attributable to NL stockholders includes:

·	income included in our equity in earnings of Kronos of $.17 per share related to an income tax benefit recognized by Kronos in the first quarter related to a European Court ruling that resulted in the favorable resolution of certain German income tax issues,

·	income of $.24 per share related to certain insurance recoveries we recognized,

·	a charge of $.43 per share related to a litigation settlement expense, and

·	a charge of $.03 per share, net of noncontrolling interest, related to recognition of a deferred income tax liability associated with a determination that certain undistributed earnings of CompX’s Taiwanese subsidiary can no longer be considered to be permanently reinvested.

- 25 -

Our 2009 net loss attributable to NL stockholders includes:

·	a litigation settlement gain of $.15 per share related to the settlement of condemnation proceedings on real property we owned,

·	income of $.04 per diluted share related to certain insurance recoveries, and

·	a write-down of assets held for sale of $.01 per diluted share.

Income (loss) from Operations

The following table shows the components of our income (loss) from operations.

	Three months ended									Six months ended
	June 30,						%			June 30,						%
	2009			2010			Change			2009			2010			Change
	(In millions)									(In millions)

CompX	$	(1.0	)	$	3.0			400	%	$	(1.9	)	$	4.7			348	%
Insurance recoveries		2.0			.1			(95	)%		2.7			18.3			(573	)%
Litigation settlement expense		-			-			-			-			(32.2	)		100	%
Litigation settlement gain		11.3			-			(100	)%		11.3			-			(100	)%
Corporate expense and other, net		(4.9	)		(2.6	)		(47	)%		(9.3	)		(7.2	)		(23	)%

Income (loss) from operations	$	7.4		$	.5					$	2.8		$	(16.4	)

Amounts attributable to CompX relate to its components products business, while the other amounts generally relate to NL. Each of these items is further discussed below.

CompX International Inc.

	Three months ended									Six months ended
	June 30,						%			June 30,						%
	2009			2010			Change			2009			2010			Change
	(In millions)									(In millions)

Net sales	$	29.2		$	34.4			18	%	$	57.7		$	67.2			16	%
Cost of sales		23.0			25.5			11	%		46.7			49.2			5	%

Gross margin	$	6.2		$	8.9					$	11.0		$	18.0

Income (loss) from operations	$	(1.0	)	$	3.0			400	%	$	(1.9	)	$	4.7			348	%

Percentage of net sales:
Cost of sales		79	%		74	%					81	%		73	%